Archives
-
Arachidonic Acid Workflows for Stroke Research
2026-08-25
Arachidonic Acid enables controlled interrogation of eicosanoid biosynthesis, oxidative stress, and neuroinflammatory signaling in cell and tissue models. This practical guide connects lipid-pathway assays with a selective hypothermic albumin perfusion study while clearly separating established findings from translational assay opportunities.
-
Psora 4: Reading Kv1.3 Biology in Context
2026-08-24
Psora 4 is a selective Kv1.3 blocker for dissecting T-cell calcium signaling and effector-memory responses. This article explains how channel architecture, assay context, and renal inflammation models shape interpretation beyond a conventional compound workflow.
-
Recombinant Human Growth Hormone: Assay Workflow
2026-08-24
Build more informative growth hormone assays by pairing somatotropin treatment with IGFBP2, THBS1, IGF-1, proliferation, and chondrocyte differentiation readouts. This workflow translates a recent mechanistic study into practical dose-finding, causal validation, and troubleshooting strategies for skeletal and pituitary growth hormone research.
-
Qushi Huoxue Ointment and MASLD Mechanisms
2026-08-23
A 2026 World Journal of Hepatology study finds that Qushi Huoxue ointment improves steatosis and inflammatory injury in a mouse model of metabolic associated steatotic liver disease through coordinated autophagy activation and ferroptosis suppression. Its integrated use of serum LC-MS/MS, network pharmacology, molecular assays, and electron microscopy provides a mechanistic framework for studying interacting liver stress pathways, while causal and clinical validation remain necessary.
-
Novobiocin, DNA Replication, and E. faecalis Protoplasts
2026-08-22
Tsuchikado and colleagues used timed Novobiocin treatment to show that DNA replication is linked to membrane-associated enlargement and vacuole formation in Enterococcus faecalis protoplasts. The study provides a useful experimental framework for separating replication inhibition, membrane growth, vacuole development, and recovery after compound removal.
-
Marein Restores Mitoxantrone Sensitivity via ABCG2
2026-08-21
The 2024 Biochemical Pharmacology study identifies marein, a flavonoid from Coreopsis tinctoria Nutt, as a competitive inhibitor of the ABCG2 drug-efflux transporter. By targeting the conserved F439 residue and increasing intracellular exposure to ABCG2 substrates such as Mitoxantrone, marein restored chemosensitivity in resistant cancer-cell models.
-
Phosbind Biotin LC: Western Blot Guide
2026-08-21
Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes when phospho-specific antibodies are unavailable or insufficient. It is suited to Western Blot workflows using streptavidin-HRP and chemiluminescence, but not to aqueous-only protocols or long-term storage of working solutions.
-
Substance P: From Mechanism to Translation
2026-08-20
A translational framework for using Substance P to connect NK-1 receptor biology with pain transmission research, neuroimmune assays, product selection, and analytical quality control.
-
HNF4A-AS1, Lipid Reprogramming, and Sorafenib Resistance
2026-08-20
A 2024 Theranostics study identifies the liver-enriched lncRNA HNF4A-AS1 as a suppressor of sorafenib resistance in hepatocellular carcinoma. Its central contribution is a mechanistic link between HNF4A-AS1, METTL3-dependent m6A modification of DECR1 mRNA, PUFA abundance, and ferroptosis sensitivity.
-
2-NBDG Glucose Uptake Assay Kit: Lab Guide
2026-08-19
A scenario-based guide to using the 2-NBDG Glucose Uptake Assay Kit, SKU K2212, for non-radioactive glucose uptake measurements in viability, cytotoxicity, and metabolic studies. It explains assay principles, controls, interpretation limits, protocol standardization, and practical product-selection criteria.
-
EZ Cap™ Human PTEN mRNA: Assay Design
2026-08-19
Learn how EZ Cap™ Human PTEN mRNA supports mechanistic cancer research through Cap 1-mediated translation, poly(A)-tail stabilization, and PTEN pathway rescue. This guide translates recent PTEN mRNA delivery findings into practical assay-selection and interpretation strategies.
-
HNF4A-AS1, Lipid Metabolism, and Sorafenib Resistance
2026-08-18
The 2024 Theranostics study identifies liver-enriched lncRNA HNF4A-AS1 as a suppressor of sorafenib resistance in hepatocellular carcinoma by regulating PUFA availability and ferroptosis. Its mechanistic model links HNF4A-AS1 to METTL3-dependent m6A modification of DECR1 mRNA, providing a framework for connecting RNA regulation with lipid metabolic adaptation in therapy-resistant HCC.
-
Novobiocin Activity Against Resistant Staphylococci
2026-08-18
The reference study directly compared mupirocin and Novobiocin susceptibility in meticillin-susceptible and meticillin-resistant staphylococci recovered from healthy dogs and dogs with superficial pyoderma. Its main contribution is a clinically relevant susceptibility framework showing that resistance phenotype and disease context can substantially influence in vitro activity, particularly for Novobiocin.
-
BH3 Mimetics Clear Senescent Breast Cancer Cells
2026-08-17
Shahbandi and colleagues showed that chemotherapy-induced senescent breast cancer cells can acquire a delayed, selective dependence on antiapoptotic BCL-2 family proteins. In TP53 wild-type models, sequential treatment with chemotherapy followed by ABT-263, with MCL1 inhibition when required, promoted tumor regression and extended survival in mice.
-
Thiazovivin: Practical ROCK Inhibitor Guidance
2026-08-17
Thiazovivin is a ROCK inhibitor used to support fibroblast reprogramming and improve human embryonic stem cell survival after trypsinization. This article provides dossier-based handling and workflow guidance for in vitro stem cell research; it is not a substitute for a validated protocol and is not intended for diagnostic, therapeutic, or clinical use.